Jasper Therapeutics Inc.-CW26JSPRWPreferred / convertible
13F holders, Q3 2024 (September 30)5holders
0new positions
0sold out
$0.20avg. 13F price*
At the end of Q3 2024, 5 institutions reported holding Jasper Therapeutics Inc.-CW26 (JSPRW) in their 13F filings, unchanged from Q2 2024. 0 opened new positions and 0 sold out. The largest holders were Cowen and Company, LLC ($441K), Walleye Capital LLC ($119K) and TENOR CAPITAL MANAGEMENT Co., L.P. ($50K).
- Company
- Jasper Therapeutics Inc.-CW26
- CUSIP
- 471871111
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 35,499 shares bought, net +35,499 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Cowen and Company, LLC | — | Add +1.6% | 2,206,248 | $441K |
| Walleye Capital LLC | — | No change | 596,014 | $119K |
| TENOR CAPITAL MANAGEMENT Co., L.P. | — | No change | 250,000 | $50K |
| Zazove Associates LLC | — | No change | 65,456 | $12K |
| Walleye Trading LLC | — | No change | 14,095 | $3K |
"% of holder's portfolio" is JSPRW's weight in each manager's 13F, not the share of Jasper Therapeutics Inc.-CW26 the manager owns.